Review: Role of genetics in susceptibility and outcome of sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 4, 2010, Pages 380-389

  Grunewald, Johan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HLA; phenotype; Sarcoidosis

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

CD4+ T LYMPHOCYTE; DISEASE PREDISPOSITION; ETHNICITY; GENETIC ASSOCIATION; GENETICS; GENOME ANALYSIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; LOFGREN SYNDROME; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; GENETIC PREDISPOSITION; IMMUNOLOGY; RISK FACTOR;

GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RISK FACTORS; SARCOIDOSIS; T-LYMPHOCYTES, HELPER-INDUCER; HLA-DRB1 CHAINS;

EID: 77955039470     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1262206     Document Type: Review

References (89)

1. Hunninghake G W., Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999 16 149-173
2. Moller D R. Pulmonary fibrosis of sarcoidosis: new approaches, old ideas. Am J Respir Cell Mol Biol 2003 29 (3, Suppl) S37-S41
3. Neville E, Walker A N., James D G. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983 52 525-533
4. Judson M A., Baughman R P., Thompson B W. et al, ACCESS Research Group. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003 20 204-211
5. Scadding J G. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years observation. BMJ 1961 2 1165-1172
6. Ma J, Gmez-Vaquero C, Montero A et al. Lfgrens syndrome revisited: a study of 186 patients. Am J Med 1999 107 240-245
7. Ma J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994 61 219-225
8. Mller-Quernheim J, Schrmann M, Hofmann S et al. Genetics of sarcoidosis. Clin Chest Med 2008 29 391-414, viii
9. Grunewald J. Genetics of sarcoidosis. Curr Opin Pulm Med 2008 14 434-439
10. Spagnolo P, du Bois R M. Genetics of sarcoidosis. Clin Dermatol 2007 25 242-249
11. Iannuzzi M C., Rybicki B A. Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc 2007 4 108-116
12. Iannuzzi M C. Genetics of sarcoidosis. Semin Respir Crit Care Med 2007 28 15-21
13. Wiman L G. Familial occurrence of sarcoidosis. Scand J Respir Dis Suppl 1972 80 115-119
14. Rybicki B A., Kirkey K L., Major M et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001 153 188-193
15. Rybicki B A., Iannuzzi M C., Frederick M M. et al, ACCESS Research Group. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001 164 2085-2091
16. Judson M A., Hirst K, Iyengar S K. et al, SAGA Study Consortium. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest 2006 130 855-862
17. Scadding J, Beresford O, Sutherland I, Leckie W, Chappell A. Familial associations in sarcoidosis: a report to the Research Committee of the British Thoracic and Tuberculosis Association. Tubercle 1973 54 87-98
18. Sverrild A, Backer V, Kyvik K O. et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 2008 63 894-896
19. Newman L S., Rose C S., Bresnitz E A. et al, ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 170 1324-1330
20. Iannuzzi M C., Rybicki B A., Teirstein A S. Sarcoidosis. N Engl J Med 2007 357 2153-2165
21. Rybicki B A., Major M, Popovich J Jr, Maliarik M J., Iannuzzi M C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997 145 234-241
22. Rybicki B A., Maliarik M J., Poisson L M. et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 2003 167 444-449
23. Pietinalho A, Ohmichi M, Lfroos A B., Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan: a comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000 17 158-166
24. Pietinalho A, Ohmichi M, Hiraga Y, Lfroos A B., Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan: a comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis 1996 13 159-166
25. Lfgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med Scand 1946 124 1-197
26. Schrmann M, Lympany P A., Reichel P et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000 162 (3 Pt 1) 861-864
27. Schrmann M, Reichel P, Mller-Myhsok B, Schlaak M, Mller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001 164 840-846
28. Iannuzzi M C., Iyengar S K., Gray-McGuire C et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005 6 509-518
29. Gray-McGuire C, Sinha R, Iyengar S et al, SAGA Study Consortium. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 2006 120 420-430
30. Valentonyte R, Hampe J, Croucher P J. et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 2005 171 1136-1141
31. Rybicki B A., Walewski J L., Maliarik M J., Kian H, Iannuzzi M C., ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005 77 491-499
32. Li Y, Wollnik B, Pabst S et al. BTNL2 gene variant and sarcoidosis. Thorax 2006 61 273-274
33. Spagnolo P, Sato H, Grutters J C. et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007 70 219-227
34. Traherne J A., Barcellos L F., Sawcer S J. et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1 15. Hum Mol Genet 2006 15 155-161
35. Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B. Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology 2008 109 117-121
36. Becker C D., Sridhar P, Iannuzzi M C. Cardiac sarcoidosis associated with BTNL2. Cardiology 2009 112 76-77, author reply 7879
37. Hofmann S, Franke A, Fischer A et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008 40 1103-1106
38. Franke A, Fischer A, Nothnagel M et al. Genome-wide association analysis in sarcoidosis and Crohns disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 2008 135 1207-1215
39. Grunewald J, Janson C H., Eklund A et al. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol 1992 22 129-135
40. Grunewald J, Olerup O, Persson U, Ohrn M B., Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci U S A 1994 91 4965-4969
41. Grunewald J, Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 2007 4 461-464
42. Moller D R., Konishi K, Kirby M, Balbi B, Crystal R G. Bias toward use of a specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 1988 82 1183-1191
43. Forman J D., Klein J T., Silver R F., Liu M C., Greenlee B M., Moller D R. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J Clin Invest 1994 94 1533-1542
44. Forrester J M., Wang Y, Ricalton N et al. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J Immunol 1994 153 4291-4302
45. Grutters J C., Sato H, Welsh K I., du Bois R M. The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 2003 29 (3, Suppl) S59-S62
46. Hedfors E, Lindstrm F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens 1983 22 200-203
47. Gardner J, Kennedy H G., Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 1984 39 19-22
48. Martinetti M, Tinelli C, Kolek V et al. The sarcoidosis map: a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995 152 557-564
49. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 156 1601-1605
50. Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB103, DRB111 or DRB112 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001 57 87-90
51. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004 169 696-702
52. Grubi Z, Zunec R, Peros-Golubici T et al. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB10301, and -DQB10201 haplotype in clinical variations of the disease. Tissue Antigens 2007 70 301-306
53. Mrazek F, Holla L I., Hutyrova B et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lfgrens syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005 65 163-171
54. Grunewald J, Shigematsu M, Nagai S et al. T-cell receptor V gene expression in HLA-typed Japanese patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1995 151 151-156
55. Grunewald J, Eklund A. Sex-specific manifestations of Lfgrens syndrome. Am J Respir Crit Care Med 2007 175 40-44
56. Grunewald J, Eklund A. Lfgrens syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 2009 179 307-312
57. Grunewald J, Eklund A. Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis. Eur Respir J 2001 17 1046-1048
58. Baughman R P., Teirstein A S., Judson M A. et al, Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001 164 (10 Pt 1) 1885-1889
59. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997 53 1-11
60. Candore G, Modica M A., Lio D et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 2003 57 274-277
61. Sato H, Grutters J C., Pantelidis P et al. HLA-DQB1 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 27 406-412
62. Voorter C E., Drent M, van den Berg-Loonen E M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1 0602-DRB1150101. Hum Immunol 2005 66 826-835
63. Foley P J., McGrath D S., Puscinska E et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001 25 272-277
64. Voorter C E., Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen E M. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 2007 70 18-27
65. Grunewald J, Wahlstrm J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 2002 57 348-352
66. Grunewald J, Berlin M, Olerup O, Eklund A. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am J Respir Crit Care Med 2000 161 (3 Pt 1) 814-818
67. Grunewald I, Eklund A. Specific bronchoalveolar lavage fluid T cells associate with disease in a pair of monozygotic twins discordant for sarcoidosis. J Intern Med 2001 250 535-539
68. Oswald-Richter K, Sato H, Hajizadeh R et al. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB11101. J Clin Immunol 2010 30 157-166
69. Rossman M D., Thompson B, Frederick M et al, ACCESS Group. HLA-DRB11101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 73 720-735
70. Song Z, Marzilli L, Greenlee B M. et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005 201 755-767
71. Saltini C, Pallante M, Puxeddu E et al. M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2008 25 100-116
72. Wahlstrm J, Dengjel J, Persson B et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 2007 117 3576-3582
73. Wahlstrm J, Dengjel J, Winqvist O et al. Autoimmune T-cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. 2009 133 353-363
74. Wahlstrm J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001 163 115-121
75. Voorter C E., Drent M, Hoitsma E, Faber K G., van den Berg-Loonen E M. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 129-132 (Pubitemid 41020018)
76. Sato H, Nagai S, du Bois R M. et al. HLA-DQB1 0602 allele is associated with splenomegaly in Japanese sarcoidosis. J Intern Med 2007 262 449-457
77. Naruse T K., Matsuzawa Y, Ota M et al. HLA-DQB1 0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 2000 56 52-57
78. Spagnolo P, Sato H, Marshall S E. et al. Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis. Invest Ophthalmol Vis Sci 2007 48 3019-3025
79. Hattori N, Niimi T, Sato S et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 27-32
80. Spagnolo P, Sato H, Grunewald J et al. A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1 0301 are independent genetic risk factors for Lfgrens syndrome. J Intern Med 2008 264 433-441
81. Idali F, Wikn M, Wahlstrm J et al. Reduced Th1 response in the lungs of HLA-DRB1 0301 patients with pulmonary sarcoidosis. Eur Respir J 2006 27 451-459
82. Idali F, Wahlstrm J, Dahlberg B et al. Altered expression of T cell immunoglobulin-mucin (TIM) molecules in bronchoalveolar lavage CD4+ T cells in sarcoidosis. Respir Res 2009 10 42
83. Seitzer U, Swider C, Stber F et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 1997 9 787-790
84. Grutters J C., Sato H, Pantelidis P et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002 165 1119-1124
85. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001 119 753-761
86. Oida T, Xu L, Weiner H L., Kitani A, Strober W. TGF-beta-mediated suppression by CD4+ CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol 2006 177 2331-2339
87. Jonth A C., Silveira L, Fingerlin T E. et al, ACCESS Group. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol 2007 179 4255-4262
88. Kruit A, Grutters J C., Ruven H J. et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006 129 1584-1591
89. Hill M R., Papafili A, Booth H et al. Functional prostaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006 174 915-922